This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A clinical trial of one or perhaps two experimental vaccines designed to protect against the Ebola Sudan virus could soon begin in Uganda, as long as the country agrees to allow the research to take place, an official of the World Health Organization said Wednesday. Read the rest…
ILiAD Biotechnologies has announced that it has selected Emmes Group to conduct the upcoming phase 3 trials of its lead pertussis vaccine candidate, BPZE1. The two companies are currently working to finalise a definitive agreement for the collaboration.
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing data science to look beyond the hype and seek definitive clinical evidence. This is especially true in the search for effective therapies to fight COVID-19, and a vaccine.
In the latest edition of What HCPs Think , CREATION.co’s Laura Marsh looks at what healthcare professionals are saying about blood clots linked to COVID-19 vaccines. This sudden increase is due to reports of rare blood clots in recipients of the COVID-19 vaccines developed by AstraZeneca and more recently Johnson & Johnson.
Health Canada has accepted Pfizer Canada’s new drug submission for a bivalent respiratory syncytial virus (RSV) vaccine for review. The vaccine will be used to prevent lower respiratory tract disease and severe lower respiratory tract disease caused by RSV in adults aged 60 and above.
Dupixent works by moderating the immune system—and that can interfere with how your body responds to certain vaccinations. Here’s why, along with which vaccines you can get and what to do if you’re on Dupixent and need a live vaccine. Can you get vaccinated while taking Dupixent? But so far, the evidence is positive.
Pharmacist Dr João Gonçalves PhD considers the real-world evidence of a recent study demonstrating the feasibility and efficacy of a personalised peptide vaccine for glioblastoma – one of the most malignant primary brain tumours in adults.
Vaccination against COVID-19 appears to provide a small but significant protection against the development of post-COVID-19 condition. Nevertheless, real-world evidence suggests that some vaccines, such as BNT162b2, have an effectiveness comparable to that reported in phase III clinical trials.
In the midst of the jubilation about the UK’s emergency approval of Pfizer/BioNTech’s COVID-19 shot in the UK came the depressingly inevitable round of anti-vaccine social media activity and lobbying.
AstraZeneca is aiming to get a next-generation vaccine targeting emerging variants approved and into the arms of patients by the autumn, company representatives said in a press conference. While the vaccine is approved in Europe, the UK and several other countries, FDA approval hangs on a study in the US.
This definition extends to those with a documented history of such an impairment, even if they are not presently experiencing a disability. While the definition of a service animal by the ADA is limited to dogs, the ADA does have specific provisions for miniature horses acting in a service animal role. What kind of animals qualify?
For instance, there is no definition in the proposed Directive of when a medicinal product is to be considered launched. Neither proposal includes a definition of what constitutes unmet medical need. However, Article 81.2 The European Commission has evidently expended significant effort in developing the proposals.
In October 2021, the World Health Organization (WHO) announced a target of fully vaccinating 70% of each country’s population against Covid-19 by the end of June 2022. But as vaccine supplies increased in the following months, the number of administered doses did not. Covid-19 vaccine delivery strategies need to be nimble.
This is the industry’s definitive conference specifically dedicated to advancing the development of both monotherapy and combinatorial therapies to improve the current standard of care for patients with TNBC.
Not too say it is as dramatic as the latter part of that statement, but it is a definite narrowing. For example in infectious diseases we have things like tropical medicine, travel vaccines, microbiology breakpoints, immunocompromised hosts, infection prevention, and regulatory requirements.
Many of my friends are concerned about starting “normal activities” after vaccination, the possibility of breakthrough infections, and the recent CDC guidance that fully vaccinated persons can go “maskless” in most situations. What is a person’s risk of COVID-19 infection if they have been fully vaccinated? First, a definition.
Early in the Covid-19 pandemic, before we had vaccines and effective medical procedures, the only ways to prevent transmission of the virus were behavioral measures like face masks and social distancing.
During the first half of 2020, surveys indicated that doctors would be reluctant to attend physical meetings in 2021, indicating preferences based mainly on fear of contracting COVID-19 and availability of vaccines. yes, if vaccines are available; 15.8% Results from 335 responses were: 47.8% yes; and 15.7%
She says she is “truly amazed” about what the industry has achieved in such a short time when it comes to innovations, vaccines and treatments. I definitely believe that there will be a balance between the two modes, but we have now all seen that we can actually exceed expectations by being fully digital.
It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. However, 2020 did not provide a definitive answer to the biggest question in neurology – which is whether pharma can produce a marketable that can slow the onset of Alzheimers.
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. The answer to this question comes back to our definition of value. And it all fuels the debate: are medicines a cost or an investment?
My definition of clinical revenue has two components: It is revenue that does not flow through a PBM. There are many examples of clinical revenue, such as MTMs, annual wellness visits, LTC consulting, food sensitivity testing, travel vaccines, and more. How is clinical revenue or service-based revenue defined?
Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Good, empathetic design allows the science to shine.
Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.
This is definitely a time for the life sciences industry to be proud of our accomplishments. The way in which the industry came together to support the development of the COVID-19 vaccines has shown that it is equally important to determine how to apply the lessons of the last year to the future. We need to be prepared to do it again.
You should not get live vaccines during treatment with Remicade, and other vaccines may be less effective. The FDA has placed boxed warnings on Remicade’s drug label , calling attention to the risk of serious infections, like tuberculosis and fungal infections. There’s also a risk of cancer, like lymphoma, in children.
The imminent rule changes will apply to crisis-relevant supplies of medical countermeasures, including both vaccines and therapeutics, where the threshold of a 'serious cross-border threat to health' is met. The new mechanism for collaboration will undoubtedly lead to other uncertainties.
Under this definition, a regulatory authority need not adopt in totality any decision reached by another regulatory authority, but they make their own decision. Dr Gouws added that WHO was the only regulatory authority to have performed inspections of Chinese manufacturers of Covid-19 vaccines during the pandemic. Joey Gouws.
Another rejected proposal was a definition of “vaccine” (vaccines are exempt from Medicaid rebates), which would have limited this term to a product that is administered prophylactically – i.e., to prevent rather than treat a disease. 1396r-8(k)(3). date of payment, date of shipment, date of invoice, etc.).
Modern healthcare: the NHS is a failing system Berry began by reflecting on Lord Prior’s curriculum vitae: barrister, trained in finance, MP, chair of Norwich hospital trust, health minister, life sciences minister, chair of NHS England – she quipped that he was ‘definitely qualified’ for the event.
The combined company will operate under the name “TuHURA Biosciences, Inc” & will trade on Nasdaq, advancing a personalized cancer vaccine platform & preclinical tumor microenvironment modulator The P-II/III study of IFx-Hu2.0 is expected to initiate in 2024.
“We’ve almost got an opportunity to take it to the next level now, because we saw this with the collaboration with the COVID vaccine development and roll-out of the vaccination programme. What I’ve seen with patient centricity over the last few years is really a broadening of the definition,” Dr Mullen explained.
The Final Guidance clarifies that, although both applicable drugs and selected drugs must be covered under a Discount Program agreement, selected drugs are excluded from the definition of an applicable drug, so they are not subject to applicable discounts during an MFP applicability year. covered insulin product or vaccine).
In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.
With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID. Once the scale of the threat was understood, the pharmaceutical industry reacted with a rapidity and agility that allowed vaccines to be developed at a record rate.
Eliminating Disparities in Medication Adherence SCAN Health Plan is focused on eliminating disparities in flu vaccination rates and medication adherence among certain members. Join the conversation from the comfort of your home or office with the IHI Forum Livestream.
Most are new or revised definitions and administrative changes, but several proposals represent new policies that should be of concern to drug manufacturers. What is noteworthy about this proposed definition is that it adds a new requirement that “[a] manufacturer must make data available to CMS to support its finding.”
If it is true that spring has sprung — and we are still awaiting definitive evidence — you might want to enjoy the great outdoors and watch the trees and flowers slowly come to life. The rotation will likely include this , this , this , this and this. And what about you?
It definitely isn't the apothecary from "A Wonderful Life," or the cozy independent store in the center of town with a telephone operator in the back and a soda shop up front. For instance, a physical location offers the ability to offer vaccinations and filling of same-day needed prescriptions (such as antibiotics, pain medications, etc.)
The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The Next Generation Lipid-Based Nanoparticles Delivery Summit is your definitive industry-led meeting to design and engineer 2nd generation of lipid nanoparticles for emerging payloads beyond RNA into clinic.
Global shortages of critical drugs are a growing issue, as demonstrated by the recent challenges around cold chains for COVID vaccines. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.
Although vaccines developed for smallpox like Bavarian Nordic’s Imvanex/Jynneos can reduce the risk of catching monkeypox, supplies are stretched, and there are currently no proven therapeutics to speed recovery in those who develop the disease. . A similar study is also planned in the US and is due to get underway shortly.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content